James is an associate in the firm's Washington, DC office and a member of the Global Antitrust/Competition practice group. His practice focuses primarily on representing pharmaceutical corporations in cutting edge class action litigation matters. He has particular experience preparing clients for depositions and trials and managing large-scale e-discovery projects. He has also assisted in preparing briefs before the Supreme Court of the United States and various federal courts of appeals.
James has a deep knowledge of the healthcare and pharmaceutical sectors. He has represented several leading global pharmaceutical companies in all aspects of federal antitrust litigation, including motions practice, discovery, summary judgment, class certification, and in preparation for trial. He has represented Pfizer in ground-breaking litigation challenging Johnson & Johnson's efforts to deter biosimilar competition in respect of its blockbuster biologic, Remicade. He has also represented Allergan/Warner Chilcott in a reversal of class certification by the First Circuit US Court of Appeals in the Asacol Antitrust Litigation.
Additionally, James maintains an active pro bono practice representing wrongfully convicted individuals and a class of low-income debtors challenging wealth-based detention in the City of Ferguson, Missouri.
While in law school, James served as an editor of the American University International Law Review and as an intern to the Honorable Eric P. Christian of the Superior Court of the District of Columbia and at the Office of International Affairs in the Criminal Division of the United States Department of Justice.